Literature DB >> 12874362

Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice.

Vladimir V Yeremeev1, Tatiana K Kondratieva, Elvira I Rubakova, Svetlana N Petrovskaya, Konstantin A Kazarian, Miroslav V Telkov, Sergej F Biketov, Arseny S Kaprelyants, Alexander S Apt.   

Abstract

It was shown recently that Mycobacterium tuberculosis expresses five proteins that are homologous to Rpf (resuscitation promoting factor), which is secreted by growing cells of Micrococcus luteus. Rpf is required to resuscitate the growth of dormant Micrococcus luteus organisms, and its homologues may be involved in mycobacterial reactivation. Mycobacterial Rpf-like products are secreted proteins, which makes them candidates for recognition by the host immune system and anti-Rpf immune responses potentially protective against reactivated tuberculosis. Here we report that the Rpf protein itself and four out of five of its mycobacterial homologues, which were administered as subunit vaccines to C57BL/6 mice, are highly immunogenic. Rpf-like proteins elicit immunoglobulin G1 (IgG1) and IgG2a responses and T-cell proliferation and stimulate production of gamma interferon, interleukin-10 (IL-10), and IL-12 but not IL-4 or IL-5. Both humoral and T-cell responses against these antigens show a high degree of cross-reactivity. Vaccination of mice with Rpf-like proteins results in a significant level of protection against a subsequent high-dose challenge with virulent M. tuberculosis H37Rv, both in terms of survival times and mycobacterial multiplication in lungs and spleens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874362      PMCID: PMC166051          DOI: 10.1128/IAI.71.8.4789-4794.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis.

Authors:  A K Arriaga; E H Orozco; L D Aguilar; G A W Rook; R Hernández Pando
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  A family of autocrine growth factors in Mycobacterium tuberculosis.

Authors:  Galina V Mukamolova; Obolbek A Turapov; Danielle I Young; Arseny S Kaprelyants; Douglas B Kell; Michael Young
Journal:  Mol Microbiol       Date:  2002-11       Impact factor: 3.501

3.  Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS.

Authors:  J Reynes; C Perez; I Lamaury; F Janbon; A Bertrand
Journal:  J Infect Dis       Date:  1989-10       Impact factor: 5.226

4.  The importance of models of infection in the study of disease resistance.

Authors:  Pierre Druilhe; Paul Hagan; Graham A W Rook
Journal:  Trends Microbiol       Date:  2002       Impact factor: 17.079

5.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

Authors:  G A Colditz; T F Brewer; C S Berkey; M E Wilson; E Burdick; H V Fineberg; F Mosteller
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

6.  Global tuberculosis incidence and mortality during 1990-2000.

Authors:  P J Dolin; M C Raviglione; A Kochi
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

7.  The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins.

Authors:  A Verbon; R A Hartskeerl; A Schuitema; A H Kolk; D B Young; R Lathigra
Journal:  J Bacteriol       Date:  1992-02       Impact factor: 3.490

8.  Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis.

Authors:  P G Pal; M A Horwitz
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

9.  Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.

Authors:  P Andersen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

Review 10.  Tuberculosis: commentary on a reemergent killer.

Authors:  B R Bloom; C J Murray
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

View more
  13 in total

1.  Analysis of immune responses against a wide range of Mycobacterium tuberculosis antigens in patients with active pulmonary tuberculosis.

Authors:  Desta Kassa; Leonie Ran; Wudneh Geberemeskel; Mekashaw Tebeje; Amelewerk Alemu; Alemayehu Selase; Belete Tegbaru; Kees L M C Franken; Annemieke H Friggen; Krista E van Meijgaarden; Tom H M Ottenhoff; Dawit Wolday; Tsehaynesh Messele; Debbie van Baarle
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

2.  Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Authors:  Cecile M Fremond; Vladimir Yeremeev; Delphine M Nicolle; Muazzam Jacobs; Valerie F Quesniaux; Bernhard Ryffel
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 3.  Vaccines for tuberculosis: novel concepts and recent progress.

Authors:  T Mark Doherty; Peter Andersen
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals.

Authors:  Susanna Commandeur; Krista E van Meijgaarden; May Young Lin; Kees L M C Franken; Annemieke H Friggen; Jan Wouter Drijfhout; Fredrik Oftung; Gro Ellen Korsvold; Annemieke Geluk; Tom H M Ottenhoff
Journal:  Clin Vaccine Immunol       Date:  2011-01-19

Review 5.  Individuality, phenotypic differentiation, dormancy and 'persistence' in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology.

Authors:  Douglas Kell; Marnie Potgieter; Etheresia Pretorius
Journal:  F1000Res       Date:  2015-07-01

6.  Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.

Authors:  Sebastian D Schuck; Henrik Mueller; Frank Kunitz; Albert Neher; Harald Hoffmann; Kees L C M Franken; Dirk Repsilber; Tom H M Ottenhoff; Stefan H E Kaufmann; Marc Jacobsen
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

7.  Expression, purification and characterization of Mycobacterium tuberculosis RpfE protein.

Authors:  Ying Xue; Yinlan Bai; Xue Gao; Hong Jiang; Limei Wang; Hui Gao; Zhikai Xu
Journal:  J Biomed Res       Date:  2012-01

8.  Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses.

Authors:  Anat Zvi; Naomi Ariel; John Fulkerson; Jerald C Sadoff; Avigdor Shafferman
Journal:  BMC Med Genomics       Date:  2008-05-28       Impact factor: 3.063

Review 9.  Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses.

Authors:  Annemieke Geluk; Krista E van Meijgaarden; Simone A Joosten; Susanna Commandeur; Tom H M Ottenhoff
Journal:  Front Immunol       Date:  2014-06-25       Impact factor: 7.561

10.  DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses.

Authors:  Jino Lee; Jihye Kim; Jeewon Lee; Sung Jae Shin; Eui-Cheol Shin
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.